Heat Biologics Stock Net Income
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Heat Biologics' long-term financial health and intrinsic value.
Heat |
Heat Biologics Company Net Income Analysis
Heat Biologics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Heat Biologics Net Income | (35.07 M) |
Most of Heat Biologics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heat Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Heat Biologics reported net income of (35.07 Million). This is 110.28% lower than that of the Healthcare sector and 150.07% lower than that of the Biotechnology industry. The net income for all United States stocks is 106.14% higher than that of the company.
Heat Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heat Biologics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heat Biologics could also be used in its relative valuation, which is a method of valuing Heat Biologics by comparing valuation metrics of similar companies.Heat Biologics is currently under evaluation in net income category among its peers.
Heat Fundamentals
| Return On Equity | -31.12 | |||
| Return On Asset | -17.1 | |||
| Current Valuation | (34.74 M) | |||
| Shares Outstanding | 25.4 M | |||
| Shares Owned By Insiders | 5.20 % | |||
| Shares Owned By Institutions | 10.77 % | |||
| Number Of Shares Shorted | 1.17 M | |||
| Price To Earning | (1.29) X | |||
| Price To Book | 0.48 X | |||
| Price To Sales | 28.62 X | |||
| Revenue | 2.11 M | |||
| Gross Profit | (16.71 M) | |||
| EBITDA | (32.93 M) | |||
| Net Income | (35.07 M) | |||
| Cash And Equivalents | 96.38 M | |||
| Cash Per Share | 3.76 X | |||
| Total Debt | 1.93 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 21.04 X | |||
| Book Value Per Share | 4.97 X | |||
| Cash Flow From Operations | (38.13 M) | |||
| Short Ratio | 4.43 X | |||
| Earnings Per Share | (1.15) X | |||
| Number Of Employees | 49 | |||
| Beta | 0.3 | |||
| Market Capitalization | 60.46 M | |||
| Total Asset | 11.75 M | |||
| Retained Earnings | (107.35 M) | |||
| Working Capital | 6.77 M | |||
| Current Asset | 11.27 M | |||
| Current Liabilities | 4.5 M | |||
| Z Score | -0.6 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Heat Stock
If you are still planning to invest in Heat Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Heat Biologics' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |